Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography

Molecular Psychiatry

Volumn 3, Issue 2, 1998, Pages 156-161

  Tiihonen, J ^a   Vilkman, H ^b   Rasanen P ^c   Ryynanen O P ^a   Hakko, H ^c   Bergman, J ^d   Hamalainen T ^a   Laakso, A ^b   Haaparanta Solin, M ^d   Solin, O ^d   Kuoppamaki M ^b   Syvalahti E ^b   Hietala, J ^e  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d TURKU PET CENTRE   (Finland)

^e TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alcoholism; Dopamine; PET; Striatum

Indexed keywords

6 FLUORODOPA; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; PRESYNAPTIC RECEPTOR;

ADULT; ALCOHOLISM; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN;

EID: 6844249441     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000365     Document Type: Article

References (31)

1. Rossetti ZL, D'Aquila PS, Hmaidan Y, Gessa GL, Serra G. Repeated treatment with imipramine potentiates cocaine-induced dopamine release and motor stimulation. Eur J Pharmacol 1991; 201: 243-245.
2. 2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis. J Pharm Exp Ther 1992; 260: 872-878.
3. Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS. β-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology (Berlin) 1991; 104: 51-56.
4. Yoshimoto K, McBride WJ, Lumeng L, Li T-K. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol 1991; 9: 17-22.
5. Kaliva PW. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Revs 1993; 18: 75-113.
6. 2 dopamine receptor agents on ethanol consumption in the high-alcohol-drinking (HAD) line of rats. Alcohol 1993; 10: 207-212.
7. 3 dopamine receptors. Science 1993; 260: 1814-1816.
8. 2 receptor gene in alcoholism. JAMA 1990; 263: 2055-2060.
9. 2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA 1991; 266: 1793-1800.
10. 2 dopamine receptor Tagl B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992; 49: 723-727.
11. Hietala J, Pohjalainen T, Heikkilä-Kallio U, West C, Salaspuro M, Syvälahti E. Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland. J Psy Gen 1997; in press.
12. 2 dopamine receptor gene (DRD2) and alcoholism. JAMA 1991; 266: 1801-1807.
13. 2 dopamine receptor genotype and cerebrospinal fluid homovanillic acid, 5-hydroxyindoleacetic acid and 3-methoxy-4-hydroxyphenylglycol in alcoholics in Finland and the United States. Acta Psychiatr Scand 1993; 86: 351-357.
14. 2 dopamine receptor genotype, linkage disequilibrium and dopamine duction in Finnish, American Indian and US Caucasian alcoholics and the population association approach in psychogenetics. Alcohol Clin Exp Res 1993; 17: 199-204.
15. 2 dopamine receptor gene is associated but not linked with alcoholism. JAMA 1991; 266: 1833-1834.
16. 2 dopamine receptor gene and alcoholism: a reappraisal. JAMA 1993; 269: 1673-1677.
17. 2 receptor genes. Trends Neurosci 1993; 16: 83-88.
18. 2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991; 48: 643-647.
19. Cloninger CR. Neurogenetic adaptive mechanisms in alcoholism. Science 1987; 236: 410-416.
20. 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology 1994; 116: 285-290.
21. Tiihonen J, Kuikka J, Bergström K, Hakola P, Karhu J, Ryynänen O-P et al. Altered striatal dopamine re-uptake site densities in habitually violent and non-violent alcoholics. Nature Med 1995; 1: 654-657.
22. Cloninger CR. The psychobiological regulation of social cooperation. Nature Med 1995; 1: 623-625.
23. Volkov ND, Wang G-J, Fowler JS, Logan J, Hitzemann R, Ding Y-S et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996; 20: 1594-1598.
24. 18F]-fluoride. J Label Comp Radipharm 1994; XXXV: 476-477.
25. Hietala J, Syvälahti E, Vuorio K, Räkköläinen V, Bergman J, Haaparanta M et al. Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet 1995; 346: 1130-1131.
26. Pellizari CA, Chen GTY, Spelbring DR, Weichselbaum RR, Chen CT. Accurate three dimensional registration of CT, PET and/or MRI images of the brain. J Comp Ass Tomography 1989; 13: 20-26.
27. Patlak CS, Blasberg RG, Fernstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
28. 18F]fluoro-L-dopa PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys. Synapse 1996; 22: 63-69.
29. Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of poststroke mood disorders. Brain 1987; 110: 1045-1059.
30. Goldman-Rakic PS. Regional and cellular fractionation of working memory. Proc Natl Acad Sci USA 1996; 93: 13473-13480.
31. Carlsson A. Dopamine autoreceptor agonists in the treatment of schizophrenia. Neuropsychopharmacology 1994; 10(3S): 119S.